KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Accumulated Expenses (2016 - 2025)

Petmed Express has reported Accumulated Expenses over the past 15 years, most recently at $8.0 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 26.74% year-over-year to $8.0 million; the TTM value through Dec 2025 reached $8.0 million, down 26.74%, while the annual FY2025 figure was $11.7 million, 65.88% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $8.0 million at Petmed Express, down from $10.8 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $11.7 million in Q1 2025 and troughed at $1.5 million in Q1 2021.
  • A 5-year average of $6.8 million and a median of $6.4 million in 2021 define the central range for Accumulated Expenses.
  • Biggest five-year swings in Accumulated Expenses: skyrocketed 201.05% in 2022 and later crashed 35.53% in 2024.
  • Year by year, Accumulated Expenses stood at $4.3 million in 2021, then decreased by 8.11% to $4.0 million in 2022, then skyrocketed by 39.66% to $5.6 million in 2023, then surged by 96.54% to $10.9 million in 2024, then decreased by 26.74% to $8.0 million in 2025.
  • Business Quant data shows Accumulated Expenses for PETS at $8.0 million in Q4 2025, $10.8 million in Q3 2025, and $10.9 million in Q2 2025.